Bandelow, Borwin

[["dc.bibliographiccitation.journal","European Neuropsychopharmacology"],["dc.bibliographiccitation.volume","16"],["dc.contributor.author","Stein, D. J."],["dc.contributor.author","Baldwin, David S."],["dc.contributor.author","Dolberg, Ornah T."],["dc.contributor.author","Despiegel, N."],["dc.contributor.author","Bandelow, Borwin"],["dc.date.accessioned","2018-11-07T09:18:50Z"],["dc.date.available","2018-11-07T09:18:50Z"],["dc.date.issued","2006"],["dc.format.extent","S468"],["dc.identifier.doi","10.1016/S0924-977X(06)70618-6"],["dc.identifier.isi","000240771302025"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/28492"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Science Bv"],["dc.publisher.place","Amsterdam"],["dc.relation.conference","19th Congress of the European-College-of-Neuropsychopharmacology"],["dc.relation.eventlocation","Paris, FRANCE"],["dc.relation.issn","0924-977X"],["dc.title","Which factors predict placebo response in anxiety disorders and major depression?"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","164"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Pharmacopsychiatry"],["dc.bibliographiccitation.lastpage","165"],["dc.bibliographiccitation.volume","42"],["dc.contributor.author","Gade, Katrin"],["dc.contributor.author","Haeussinger, Constanze"],["dc.contributor.author","Bandelow, Borwin"],["dc.date.accessioned","2018-11-07T08:28:29Z"],["dc.date.available","2018-11-07T08:28:29Z"],["dc.date.issued","2009"],["dc.description.abstract","We present a patient diagnosed with atypical anorexia accompanied by mainly food intake-related OCD-like symptoms who failed to respond to clomipramine, risperidone, fluoxetine and olanzapine treatment, cognitive behavioural therapy (CBT) and psychodynamic psychotherapy. Naltrexone at a dose of 50 mg/d was added to the current medication consisting of fluoxetine and olanzapine, which resulted in a significant reduction of obsessive-compulsive symptoms as measured by Yale-Brown obsessive-compulsive scale (Y-BOCS) after 8 weeks into naltrexone treatment. The patient's eating behaviour normalised, resulting in an increased body mass index and substantial improvement in his quality of life."],["dc.identifier.doi","10.1055/s-0028-1128114"],["dc.identifier.isi","000268143700007"],["dc.identifier.pmid","19585396"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/16433"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Georg Thieme Verlag Kg"],["dc.relation.issn","0176-3679"],["dc.title","Atypical Anorexia in a Male Patient Accompanied by Strong Obsessive-compulsive Symptoms Successfully Treated with Naltrexone"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","32"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","PSYCHOPHARMAKOTHERAPIE"],["dc.bibliographiccitation.lastpage","33"],["dc.bibliographiccitation.volume","12"],["dc.contributor.author","Degner, Detlef"],["dc.contributor.author","Fiege, O."],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Grohmann, Renate"],["dc.contributor.author","Ruther, Eckart"],["dc.date.accessioned","2018-11-07T08:47:19Z"],["dc.date.available","2018-11-07T08:47:19Z"],["dc.date.issued","2005"],["dc.identifier.isi","000227807100009"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/20924"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wissenschaftliche Verlag Mbh"],["dc.relation.issn","0944-6877"],["dc.title","Oculogyric crisis under aripiprazol in combination with fluoxetin"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","87"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","European Archives of Psychiatry and Clinical Neuroscience"],["dc.bibliographiccitation.lastpage","106"],["dc.bibliographiccitation.volume","265"],["dc.contributor.author","Moeller, Hans-Juergen"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Bauer, Michael"],["dc.contributor.author","Hampel, Harald"],["dc.contributor.author","Herpertz, Sabine C."],["dc.contributor.author","Soyka, Michael"],["dc.contributor.author","Barnikol, Utako Birgit"],["dc.contributor.author","Lista, Simone"],["dc.contributor.author","Severus, Emanuel"],["dc.contributor.author","Maier, Wolfgang"],["dc.date.accessioned","2018-11-07T10:00:29Z"],["dc.date.available","2018-11-07T10:00:29Z"],["dc.date.issued","2015"],["dc.description.abstract","Part 1 of this paper discussed several more general aspects of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and offered a detailed, paradigmatic analysis of changes made to the chapter on depressive disorders. This second part focusses on several other disorders, including bipolar and schizophrenia spectrum disorders. The respective changes and their possible consequences are discussed under consideration of traditional psychiatric classification, particularly from the perspective of European traditions and on the basis of a PubMed search and review papers. The general conclusion is that even seemingly small changes such as the introduction of the mixed feature specifier can have far-reaching consequences. Contrary to the original plans, DSM-5 has not radically changed to become a primarily dimensional diagnostic system but has preserved the categorical system for most disorders. The ambivalence of the respective decision-making becomes apparent from the last minute decision to change the classification of personality disorders from dimensional back to categorical. The advantages and disadvantages of the different approaches are discussed in this context. In DSM-5, only the chapter on addictive disorders has a somewhat dimensional structure. Also in contrast to the original intentions, DSM-5 has not used a more neurobiological approach to disorders by including biological markers to increase the objectivity of psychiatric diagnoses. Even in the most advanced field in terms of biomarkers, the neurocognitive disorders, the primarily symptom-based, descriptive approach has been preserved and the well-known amyloid-related and other biomarkers are not included. This is because, even after so many years of biomarker research, the results are still not considered to be robust enough to use in clinical practice."],["dc.identifier.doi","10.1007/s00406-014-0521-9"],["dc.identifier.isi","000350305500002"],["dc.identifier.pmid","25155875"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/37821"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","Heidelberg"],["dc.relation.issn","1433-8491"],["dc.relation.issn","0940-1334"],["dc.title","DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences-part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","Der Nervenarzt"],["dc.contributor.author","Zwanzger, P."],["dc.contributor.author","Singewald, N."],["dc.contributor.author","Bandelow, B."],["dc.date.accessioned","2021-04-14T08:30:42Z"],["dc.date.available","2021-04-14T08:30:42Z"],["dc.date.issued","2021"],["dc.identifier.doi","10.1007/s00115-020-01051-3"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/83343"],["dc.language.iso","de"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1433-0407"],["dc.relation.issn","0028-2804"],["dc.title","Pharmakotherapie von Angsterkrankungen – leitliniengerechte Therapie und Neuentwicklungen"],["dc.title.translated","Pharmacotherapy of anxiety disorders—Guideline-conform treatment and new developments"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","American Journal of Medical Genetics Part B Neuropsychiatric Genetics"],["dc.bibliographiccitation.volume","138B"],["dc.contributor.author","Hohoff, Christa"],["dc.contributor.author","Jung, A."],["dc.contributor.author","Freitag, Christine M."],["dc.contributor.author","Willis-Owen, S. A."],["dc.contributor.author","Ponath, G."],["dc.contributor.author","Krakowitzky, Petra"],["dc.contributor.author","Fritze, Juergen"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Franke, Petra E."],["dc.contributor.author","Fimmers, Rolf"],["dc.contributor.author","Nothen, M. M."],["dc.contributor.author","Flint, J."],["dc.contributor.author","Deckert, J."],["dc.date.accessioned","2018-11-07T10:55:48Z"],["dc.date.available","2018-11-07T10:55:48Z"],["dc.date.issued","2005"],["dc.format.extent","11"],["dc.identifier.isi","000232357300032"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/49868"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-liss"],["dc.publisher.place","Hoboken"],["dc.relation.conference","13th World Congress on Psychiatric Genetics"],["dc.relation.eventlocation","Boston, MA"],["dc.relation.issn","1552-4841"],["dc.title","Investigation of RGS2 and RGS13 gene polymorphisms in human panic disorder"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","314"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","International Journal of Psychiatry in Clinical Practice"],["dc.bibliographiccitation.lastpage","315"],["dc.bibliographiccitation.volume","11"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Bobes, Julio"],["dc.contributor.author","Ahokas, Antti"],["dc.contributor.author","Eggens, Ivan"],["dc.contributor.author","Liu, S."],["dc.contributor.author","Brecher, M."],["dc.date.accessioned","2018-11-07T11:06:44Z"],["dc.date.available","2018-11-07T11:06:44Z"],["dc.date.issued","2007"],["dc.identifier.isi","000251026900051"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/52385"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Taylor & Francis As"],["dc.publisher.place","Oslo"],["dc.relation.issn","1365-1501"],["dc.title","Results from a phase III study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","948"],["dc.bibliographiccitation.issue","10"],["dc.bibliographiccitation.journal","The Canadian Journal of Psychiatry"],["dc.bibliographiccitation.lastpage","952"],["dc.bibliographiccitation.volume","46"],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Tichauer, G. A."],["dc.contributor.author","Spath, C."],["dc.contributor.author","Broocks, Andreas"],["dc.contributor.author","Hajak, Goran"],["dc.contributor.author","Bleich, Stefan"],["dc.contributor.author","Ruther, Eckart"],["dc.date.accessioned","2018-11-07T11:20:34Z"],["dc.date.available","2018-11-07T11:20:34Z"],["dc.date.issued","2001"],["dc.description.abstract","Objective: The association between separation anxiety in childhood and actual separation experiences during childhood has not yet been investigated in patients with panic disorder. Methods: In 115 patients with panic disorder with or without agoraphobia and in 124 control subjects without a history of psychiatric illness, we assessed separation anxiety during childhood, retrospectively, using DSM-IV and ICD-10 criteria and the Separation Anxiety Symptom Inventory (SASI). In addition, actual separation experiences from age 0 to 15 years were assessed, retrospectively. Results: A total of 22.6% of the patients and 4.8% of the Control subjects fulfilled both DSM-IV and ICD-10 criteria for childhood separation anxiety (chi(2) = 11.8; P < 0.0001). Further, 57.4% ofthepatients and 37.9% of the control subjects reported actual separation experiences during their childhood (chi(2) = 9. 09, P < 0.003). Separation anxiety and actual separation experiences, however, were independent of each other. Conclusion: These results suggest that separation anxiety during childhood is not a consequence of actual traumatic separation experiences in panic disorder patients."],["dc.identifier.isi","000173099800007"],["dc.identifier.pmid","11816316"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/55564"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Canadian Psychiatric Assoc"],["dc.relation.issn","0706-7437"],["dc.title","Separation anxiety and actual separation experiences during childhood in patients with panic disorder"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","363"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Psychology Health & Medicine"],["dc.bibliographiccitation.lastpage","374"],["dc.bibliographiccitation.volume","18"],["dc.contributor.author","Passie, Torsten"],["dc.contributor.author","Schneider, Udo"],["dc.contributor.author","Borsutzky, Mathias"],["dc.contributor.author","Breyer, Roger"],["dc.contributor.author","Emrich, Hinderk M."],["dc.contributor.author","Bandelow, Borwin"],["dc.contributor.author","Schmid-Ott, Gerhard"],["dc.date.accessioned","2018-11-07T09:25:12Z"],["dc.date.available","2018-11-07T09:25:12Z"],["dc.date.issued","2013"],["dc.description.abstract","The Binocular Depth Inversion Test (BDIT) measures a common illusion of visual perception whereby implausible objects are seen as normal, e.g., a hollow face is perceived as a normal, convex face. Such inversion is frequent, especially for objects with a high degree of familiarity. Under normal conditions, cognitive factors apparently override the binocular disparity cues of stereopsis. This internal mechanism of censorship of perception, which balances top-down and bottom-up processes of perception to come to a cognitive coherence, which is congruent to previous experience and concepts, appears to be disturbed in (pro-)psychotic states. The BDIT has been shown to be a sensitive measure of impaired higher visual processing and conceptual cognition common to conditions including schizophrenia, cannabinoid-intoxication, and sleep deprivation but not depression. In this pilot study, we tested the performance of patients with anxiety disorders (ICD-10 F40 and F41) compared to matched controls using the BDIT paradigm. Anxiety patients scored significantly higher on the BDIT than controls, in a range comparable to propsychotic conditions. The findings suggest that anxiety patients could have abnormalities in central perceptual processing, top-down processing (conceptual cognition), and reality testing similar to (pro-)psychotic conditions. Implications of these findings are discussed in relation to therapeutic interventions with anxiety disorders."],["dc.identifier.doi","10.1080/13548506.2012.722649"],["dc.identifier.isi","000318347600011"],["dc.identifier.pmid","23186162"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/30010"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Routledge Journals, Taylor & Francis Ltd"],["dc.relation.issn","1354-8506"],["dc.title","Impaired perceptual processing and conceptual cognition in patients with anxiety disorders: A pilot study with the binocular depth inversion paradigm"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","Der Nervenarzt"],["dc.bibliographiccitation.volume","78"],["dc.contributor.author","Bandelow, Borwin"],["dc.date.accessioned","2018-11-07T10:57:26Z"],["dc.date.available","2018-11-07T10:57:26Z"],["dc.date.issued","2007"],["dc.format.extent","510"],["dc.identifier.isi","000253318801497"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/50248"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","New york"],["dc.relation.issn","0028-2804"],["dc.title","New therapy options for anxiety and compulsive disorder"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]